Natera, Inc. (NTRA): Total Liabilities
$685.93M
As of 2025-12-31
$836.00M
As of 2026-06-30
-0.1%
3-year compound annual growth
+9.0%
5-year compound annual growth
+23.9%
10-year compound annual growth
| Period ended | Total Liabilities | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $685.93M | +47.4% | 2026-02-27, Balance as of period end |
| 2024-12-31 | $465.31M | -31.2% | 2026-02-27, Balance as of period end |
| 2023-12-31 | $676.37M | -1.8% | 2025-02-28, Balance as of period end |
| 2022-12-31 | $688.73M | +18.1% | 2024-02-29, Balance as of period end |
| 2021-12-31 | $583.18M | +30.8% | 2023-03-01, Balance as of period end |
| 2020-12-31 | $445.92M | +46.7% | 2022-02-25, Balance as of period end |
| 2019-12-31 | $303.94M | +28.8% | 2021-02-26, Balance as of period end |
| 2018-12-31 | $236.01M | +24.7% | 2020-03-02, Balance as of period end |
| 2017-12-31 | $189.20M | +81.6% | 2019-03-15, Balance as of period end |
| 2016-12-31 | $104.20M | +29.5% | 2018-03-15, Balance as of period end |
| 2015-12-31 | $80.47M | +48.1% | 2017-03-16, Balance as of period end |
| 2014-12-31 | $54.35M | n/a | 2016-03-24, Balance as of period end |
Total Liabilities at similar companies
| Company | Year ended | Total Liabilities | Change YoY |
|---|---|---|---|
| Natera, Inc. (NTRA) | 2025-12-31 | $685.93M | +47.4% |
| RadNet, Inc. (RDNT) | 2025-12-31 | $2.40B | +11.6% |
| Fortrea Holdings Inc. (FTRE) | 2025-12-31 | $2.15B | -2.9% |
| Guardant Health, Inc. (GH) | 2025-12-31 | $2.11B | +30.0% |
| Caris Life Sciences, Inc. (CAI) | 2025-12-31 | $548.36M | -11.7% |
| Veracyte, Inc. (VCYT) | 2025-12-31 | $96.44M | -22.3% |
| Labcorp Holdings Inc. (LH) | 2025-12-31 | $9.76B | -5.4% |
| CareDx, Inc. (CDNA) | 2025-12-31 | $110.13M | -2.2% |
| Castle Biosciences Inc (CSTL) | 2025-12-31 | $107.68M | +42.8% |
Compare NTRA, RDNT, FTRE, GH side by side · Screen every company in Services-Medical Laboratories ↗